Tegozid XP 250mg/31.25mg Injection
Marketer
Torance Healthcare Pvt Ltd
Salt Composition
Ceftazidime (250mg) + Tazobactum (31.25mg)
Overview Tegozid XP 250mg/31.25mg Injection
Combiflox 250mg/31.25mg Injection, a dual-action antibiotic, combats diverse bacterial infections by inhibiting microbial proliferation and halting infection spread. Administration must be solely under medical guidance. Complete the prescribed course, even with symptom improvement; premature cessation may compromise efficacy. Common side effects include nausea, vomiting, diarrhea, and dyspepsia. Report worsening side effects immediately to your physician. Seek urgent medical attention for allergic reactions (e.g., rash, itching, edema, dyspnea). Inform your doctor of all concurrent medications, including those for pre-existing conditions. Pregnant or lactating individuals require medical consultation before use. Alcohol consumption should be avoided due to potential increased drowsiness. While generally non-impairing to driving ability, refrain from driving if drowsiness or dizziness occurs. Adequate rest, balanced nutrition, and sufficient hydration promote faster recovery. Your physician may order lab tests to monitor treatment response.
Uses of Tegozid XP 250mg/31.25mg Injection
Infections caused by bacteria
Major Benefits of Tegozid XP 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
Common Side effects of Tegozid XP 250mg/31.25mg Injection:
- Nausea
- Vomiting
- Diarrhea
- Stomach pain
- Increased liver enzymes
- Allergic reaction
How to use Tegozid XP 250mg/31.25mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Tegozid XP 250mg/31.25mg Injection works:
Ceftazidime/Tazobactam Injection (Tegozid XP 250mg/31.25mg) combines the antibiotic Ceftazidime with the beta-lactamase inhibitor Tazobactam. Ceftazidime disrupts bacterial cell wall synthesis, hindering bacterial survival. Tazobactam counteracts bacterial resistance mechanisms, thereby bolstering Ceftazidime's antibacterial effect.
SAFETY ADVICE
AlcoholSAFE
Ingestion of alcohol alongside Tegozid XP 250mg/31.25mg Injection poses no known adverse reactions.
PregnancySAFE IF PRESCRIBED
The injectable medication Tegozid XP 250mg/31.25mg is typically deemed safe for use during pregnancy. Preclinical trials in animals revealed minimal or no negative consequences for fetal development; nevertheless, data from human studies are scarce.
Breast feedingSAFE IF PRESCRIBED
Administration of Tegozid XP 250mg/31.25mg Injection is considered safe for breastfeeding mothers. Research in humans indicates negligible transfer of the medication into breast milk, posing no identified risk to the infant.
DrivingUNSAFE
Administering Tegozid XP 250mg/31.25mg Injection may induce drowsiness, blurred vision, or dizziness. Operating a vehicle is prohibited while experiencing these effects.
KidneyCAUTION
Administering Tegozid XP 250mg/31.25mg Injection requires careful consideration in individuals with impaired renal function. Dosage modification of Tegozid XP 250mg/31.25mg Injection might be necessary. Physician consultation is advised.
LiverCAUTION
Patients with severe hepatic impairment should use Tegozid XP 250mg/31.25mg Injection cautiously, potentially requiring dosage modification. Medical advice is recommended.
What if you forget to take Tegozid XP 250mg/31.25mg Injection :
Omit a dose of Tegozid XP 250mg/31.25mg Injection? Seek your physician's advice.
Facts to Know About Tegozid XP 250mg/31.25mg Injection
| Label | Value |
|---|---|
| Developing Habits | No. |
| Type of Therapy | Antimicrobial Agents |
3,018 People bought this recently